{"transactions":[{"id":856090,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-03-06T16:21:10.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":788},"source":{"system":"sec-edgar","filing":"0001872398-26-000003","document":"form4-03062026_090306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000003/form4-03062026_090306.xml","form_type":"4"}},{"id":856089,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-06T16:21:10.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":282,"price":21.31,"value":6009.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":21285,"source":{"system":"sec-edgar","filing":"0001872398-26-000003","document":"form4-03062026_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000003/form4-03062026_090306.xml","form_type":"4"}},{"id":856088,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-06T16:21:10.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":788,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21567,"source":{"system":"sec-edgar","filing":"0001872398-26-000003","document":"form4-03062026_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000003/form4-03062026_090306.xml","form_type":"4"}},{"id":868196,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48 of the total option award shall vest monthly, subject to the reporting person's continued service through each vesting date, with the first tranche vesting on April 1, 2026."}],"balance_after":175000,"derivative":{"exercise_price":20.55,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868195,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date."}],"balance_after":40000,"derivative":{"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868194,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":false,"shares":7750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 2, 2026, subject to continued service through each vesting date."}],"balance_after":23250,"derivative":{"expiration_date":"2029-03-02","underlying":"Common Stock","underlying_shares":7750},"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868193,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":5000,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868192,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":688,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868191,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2779,"price":20.55,"value":57108.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":20779,"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868190,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-02","kind":"exercise","planned":false,"acquired":true,"shares":7750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23558,"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868189,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1271,"price":20.47,"value":26017.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":15808,"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868188,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17079,"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":868187,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:48:50.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14579,"source":{"system":"sec-edgar","filing":"0001872398-26-000002","document":"form4-03032026_110347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239826000002/form4-03032026_110347.xml","form_type":"4"}},{"id":967780,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-12-16T20:47:26.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award vested or vests as to 1/4th of the total award annually, subject to continued service through each vesting date, with the first tranche vested on December 1, 2024.  The reported transaction represents the deferred vesting and settlement of a tranche of this award pursuant to the terms of the reporting person's award agreement with the Issuer."}],"balance_after":5000,"derivative":{"expiration_date":"2027-12-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001872398-25-000005","document":"form4-12172025_011222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239825000005/form4-12172025_011222.xml","form_type":"4"}},{"id":967779,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T20:47:26.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":894,"price":8.015,"value":7165.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs; does not represent a sale by the reporting person."}],"balance_after":13891,"source":{"system":"sec-edgar","filing":"0001872398-25-000005","document":"form4-12172025_011222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239825000005/form4-12172025_011222.xml","form_type":"4"}},{"id":967778,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T20:47:26.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14785,"source":{"system":"sec-edgar","filing":"0001872398-25-000005","document":"form4-12172025_011222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239825000005/form4-12172025_011222.xml","form_type":"4"}},{"id":1017675,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-16T08:17:03.000Z","date":"2025-10-15","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":0.8009,"value":10011.25,"ownership":{"direct":true},"balance_after":122850,"source":{"system":"sec-edgar","filing":"0001872398-25-000004","document":"form4-10162025_121000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000187239825000004/form4-10162025_121000.xml","form_type":"4"}},{"id":1055846,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-08-26T21:20:43.000Z","date":"2025-08-09","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested or vest as to 1/4th of the total award annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-25-023083","document":"form4-08272025_010839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925023083/form4-08272025_010839.xml","form_type":"4"}},{"id":1055845,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-26T21:20:43.000Z","date":"2025-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":6708,"price":0.8,"value":5366.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":110350,"source":{"system":"sec-edgar","filing":"0001415889-25-023083","document":"form4-08272025_010839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925023083/form4-08272025_010839.xml","form_type":"4"}},{"id":1055844,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-26T21:20:43.000Z","date":"2025-08-09","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117058,"source":{"system":"sec-edgar","filing":"0001415889-25-023083","document":"form4-08272025_010839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925023083/form4-08272025_010839.xml","form_type":"4"}},{"id":1175721,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2025-04-08T16:12:07.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":310000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 2, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":310000,"derivative":{"expiration_date":"2029-03-02","underlying":"Common Stock","underlying_shares":310000},"source":{"system":"sec-edgar","filing":"0001415889-25-010385","document":"form4-04082025_080404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925010385/form4-04082025_080404.xml","form_type":"4"}},{"id":1175720,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-08T16:12:07.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":620000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total award monthly, beginning on May 4, 2025, with 100% of the award being vested and exercisable on April 4, 2029, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":620000,"derivative":{"exercise_price":0.55,"expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":620000},"source":{"system":"sec-edgar","filing":"0001415889-25-010385","document":"form4-04082025_080404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925010385/form4-04082025_080404.xml","form_type":"4"}},{"id":1219831,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-06T16:06:54.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":7875,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001415889-25-007182","document":"form4-03062025_090350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925007182/form4-03062025_090350.xml","form_type":"4"}},{"id":1219830,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-06T16:06:54.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2334,"price":1.42,"value":3314.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":98308,"source":{"system":"sec-edgar","filing":"0001415889-25-007182","document":"form4-03062025_090350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925007182/form4-03062025_090350.xml","form_type":"4"}},{"id":1219829,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-06T16:06:54.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100642,"source":{"system":"sec-edgar","filing":"0001415889-25-007182","document":"form4-03062025_090350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925007182/form4-03062025_090350.xml","form_type":"4"}},{"id":1229452,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-04T18:42:06.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-006712","document":"form4-03042025_110302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925006712/form4-03042025_110302.xml","form_type":"4"}},{"id":1229451,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-04T18:42:06.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":13750,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001415889-25-006712","document":"form4-03042025_110302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925006712/form4-03042025_110302.xml","form_type":"4"}},{"id":1229450,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-04T18:42:06.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9450,"price":1.59,"value":15025.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":92767,"source":{"system":"sec-edgar","filing":"0001415889-25-006712","document":"form4-03042025_110302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925006712/form4-03042025_110302.xml","form_type":"4"}},{"id":1229449,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-04T18:42:06.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":102217,"source":{"system":"sec-edgar","filing":"0001415889-25-006712","document":"form4-03042025_110302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925006712/form4-03042025_110302.xml","form_type":"4"}},{"id":1229448,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-04T18:42:06.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77217,"source":{"system":"sec-edgar","filing":"0001415889-25-006712","document":"form4-03042025_110302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588925006712/form4-03042025_110302.xml","form_type":"4"}},{"id":1345289,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-12-03T16:09:46.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on December 1, 2024, subject to continued service through each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2027-12-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-028066","document":"form4-12032024_091242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924028066/form4-12032024_091242.xml","form_type":"4"}},{"id":1345288,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-12-03T16:09:46.000Z","date":"2024-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":8920,"price":2.69,"value":23994.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":70342,"source":{"system":"sec-edgar","filing":"0001415889-24-028066","document":"form4-12032024_091242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924028066/form4-12032024_091242.xml","form_type":"4"}},{"id":1345287,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-12-03T16:09:46.000Z","date":"2024-12-01","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79262,"source":{"system":"sec-edgar","filing":"0001415889-24-028066","document":"form4-12032024_091242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924028066/form4-12032024_091242.xml","form_type":"4"}},{"id":1434946,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-08-13T16:16:55.000Z","date":"2024-08-09","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested or vest as to 1/4th of the total award annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":18750,"derivative":{"expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-24-021157","document":"form4-08132024_080852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924021157/form4-08132024_080852.xml","form_type":"4"}},{"id":1434945,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-08-13T16:16:55.000Z","date":"2024-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":6689,"price":3.12,"value":20869.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":54262,"source":{"system":"sec-edgar","filing":"0001415889-24-021157","document":"form4-08132024_080852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924021157/form4-08132024_080852.xml","form_type":"4"}},{"id":1434944,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-08-13T16:16:55.000Z","date":"2024-08-09","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60951,"source":{"system":"sec-edgar","filing":"0001415889-24-021157","document":"form4-08132024_080852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924021157/form4-08132024_080852.xml","form_type":"4"}},{"id":1471092,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T19:48:13.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.569,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-077005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000095017024077005/ownership.xml","form_type":"4"}},{"id":1589372,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-03-07T16:26:46.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":100000,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-007183","document":"form4-03072024_090340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924007183/form4-03072024_090340.xml","form_type":"4"}},{"id":1589371,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-07T16:26:46.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.54,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-007183","document":"form4-03072024_090340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924007183/form4-03072024_090340.xml","form_type":"4"}},{"id":1592076,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-03-06T16:21:38.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":15750,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001415889-24-007020","document":"form4-03062024_090325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924007020/form4-03062024_090325.xml","form_type":"4"}},{"id":1592075,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-03-06T16:21:38.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2209,"price":4.79,"value":10581.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":42201,"source":{"system":"sec-edgar","filing":"0001415889-24-007020","document":"form4-03062024_090325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924007020/form4-03062024_090325.xml","form_type":"4"}},{"id":1592074,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-03-06T16:21:38.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":true,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44410,"source":{"system":"sec-edgar","filing":"0001415889-24-007020","document":"form4-03062024_090325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924007020/form4-03062024_090325.xml","form_type":"4"}},{"id":1597440,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-03-05T16:32:42.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award vests as to 1/4th of the total award annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":20625,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001415889-24-006687","document":"form4-03052024_090320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924006687/form4-03052024_090320.xml","form_type":"4"}},{"id":1597439,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-03-05T16:32:42.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":2038,"price":4.95,"value":10088.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":36535,"source":{"system":"sec-edgar","filing":"0001415889-24-006687","document":"form4-03052024_090320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924006687/form4-03052024_090320.xml","form_type":"4"}},{"id":1597438,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-03-05T16:32:42.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38573,"source":{"system":"sec-edgar","filing":"0001415889-24-006687","document":"form4-03052024_090320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000141588924006687/form4-03052024_090320.xml","form_type":"4"}},{"id":1724060,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-12-04T16:19:07.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on December 1, 2024, subject to continued service through each vesting date."}],"balance_after":100000,"derivative":{"expiration_date":"2027-12-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-057206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123057206/doc4.xml","form_type":"4"}},{"id":1724059,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-04T16:19:07.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on January 1, 2024, with 100% of the total shares vested and exercisable on December 1, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.75,"expiration_date":"2033-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-057206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123057206/doc4.xml","form_type":"4"}},{"id":1810042,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-08-11T16:16:04.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":37500,"derivative":{"expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-23-045434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123045434/doc4.xml","form_type":"4"}},{"id":1810041,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-11T16:16:04.000Z","date":"2023-08-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":6483,"price":4.22,"value":27358.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":31698,"source":{"system":"sec-edgar","filing":"0001209191-23-045434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123045434/doc4.xml","form_type":"4"}},{"id":1810040,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-11T16:16:04.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38181,"source":{"system":"sec-edgar","filing":"0001209191-23-045434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123045434/doc4.xml","form_type":"4"}},{"id":1861103,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:19:34.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.5,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-036008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123036008/doc4.xml","form_type":"4"}},{"id":1966371,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:26:24.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":23625,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001209191-23-016742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123016742/doc4.xml","form_type":"4"}},{"id":1966370,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:26:24.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":27500,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-23-016742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123016742/doc4.xml","form_type":"4"}},{"id":1966369,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T16:26:24.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 1, 2023, with 100% of the total shares vested and exercisable on March 1, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.79,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-016742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123016742/doc4.xml","form_type":"4"}},{"id":1966368,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:26:24.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":3211,"price":5.79,"value":18591.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":19431,"source":{"system":"sec-edgar","filing":"0001209191-23-016742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123016742/doc4.xml","form_type":"4"}},{"id":1966367,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T16:26:24.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":7875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":22642,"source":{"system":"sec-edgar","filing":"0001209191-23-016742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919123016742/doc4.xml","form_type":"4"}},{"id":2188401,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-11T18:58:40.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36) of the shares subject to the option shall vest monthly beginning on the one month anniversary of August 10, 2022 (the \"Vesting Commencement Date\"), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date."}],"balance_after":80000,"derivative":{"exercise_price":3.69,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-22-045492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919122045492/doc4.xml","form_type":"4"}},{"id":2189768,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-08-10T18:16:37.000Z","date":"2022-08-09","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":56250,"derivative":{"expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-045297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919122045297/doc4.xml","form_type":"4"}},{"id":2189767,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-10T18:16:37.000Z","date":"2022-08-09","kind":"tax_withholding","acquired":false,"shares":6483,"price":6.6,"value":42787.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":14767,"source":{"system":"sec-edgar","filing":"0001209191-22-045297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919122045297/doc4.xml","form_type":"4"}},{"id":2189766,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-10T18:16:37.000Z","date":"2022-08-09","kind":"exercise","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares acquired under the issuer's employee stock purchase plan on March 15, 2022."}],"balance_after":21250,"source":{"system":"sec-edgar","filing":"0001209191-22-045297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919122045297/doc4.xml","form_type":"4"}},{"id":2348311,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:33:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":31500,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-22-016865","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919122016865/doc4.xml","form_type":"4"}},{"id":2348310,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T19:33:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":42000,"derivative":{"exercise_price":8.17,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-22-016865","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919122016865/doc4.xml","form_type":"4"}},{"id":2607137,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-08-11T17:21:29.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-050956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919121050956/doc4.xml","form_type":"4"}},{"id":2607136,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":62312,"kind":"person","name":"Chung Jane","position":1,"cik":"0001872398","reported_name":"Chung Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T17:21:29.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4th of the total shares on August 9, 2022 and then 1/48th of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on August 9, 2025, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":160000,"derivative":{"exercise_price":18.37,"expiration_date":"2031-08-08","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001209191-21-050956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872398/000120919121050956/doc4.xml","form_type":"4"}}]}